Clinical Trial Results:
            A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Seven Arm, Four-Period Cross-over, Incomplete Block Design, 7-Day Dosing Study to Assess the Dose-Response, Safety, and Efficacy of EP-101 in Subjects with Moderate to Severe COPD
    
|     Summary | |
|     EudraCT number | 2011-001810-32 | 
|     Trial protocol | GB | 
|     Global completion date | 
                                    13 Dec 2011
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1 | 
|     This version publication date | 
                                    14 Jul 2017
                             | 
|     First version publication date | 
                                    14 Jul 2017
                             | 
|     Other versions | v2 | 
|     Summary report(s) | EP-101-03 | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
